Company / Cash per Share
Progyny Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.32
FY2025
5-year range
$0.91 / $1.68
FY2021-FY2025
Trend
-21.9%
vs FY2024
Sector context
#109 of 150
Health Care
What the data says
At $1.32, Progyny's cash per share ranks #109 of 150 in the Health Care sector. Cash per Share has fluctuated over the past 8 years, ranging from $0.02 in FY2018 to $3.88 in FY2019.
Based on SEC 10-K filings.
1.32 in FY2025 with a 5-year CAGR of +13.1%.
Improved from $1.04 to $1.32 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Sector benchmark
#109 of 150 in Health CareTop 73% of 150This company $1.32 Sector average $27.11
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 21.9% year-over-year.
- Ranks #109 out of 150 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.32 | -21.9% |
| FY2024 | $1.68 | +61.5% |
| FY2023 | $1.04 | -20.9% |
| FY2022 | $1.32 | +44.7% |
| FY2021 | $0.91 | +28.3% |
| FY2020 | $0.71 | -81.7% |
| FY2019 | $3.88 | +16809.7% |
| FY2018 | $0.02 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026